澳门葡京网赌游戏R&D: Turning science into medicine

Introducing 澳门葡京网赌游戏R&D

We are driven by science, 科学联合, 每一天, we push the boundaries of science to deliver life-changing medicines.

澳门葡京网赌游戏

We are never complacent about scientific discovery and development, always pushing our R&D productivity, searching for new knowledge and the next breakthrough.

Read about our approach to R&D

MILTON disease prediction

Our cutting-edge machine learning research tool enables early disease detection for drug discovery and beyond

Discover more about MILTON

细胞疗法

细胞疗法 is a promising, rapidly advancing field with the potential to transform treatment across disease areas with significant unmet needs.

Learn more about our cell therapy ambition

澳门葡京赌博游戏的人民 are our power

Our business and scientific culture is diverse, inclusive and collaborative, and we do everything in our power to enable all our people to be the best they can be.

Qing-Dong王

Senior Principal Scientist, 生物科学, 研究 and Early 发展, 心血管、肾 and 新陈代谢, 澳门葡京赌博游戏R&D

奴隶Petrovski

VP, Head of Centre for Genomics 研究, Discovery Sciences, R&D

马林Lemurell

Executive Director and Head of Medicinal Chemistry, 研究 and Early 发展, 心血管、肾 and 新陈代谢, 澳门葡京赌博游戏R&D

Meet more of our people

肿瘤学

心血管、肾 & 新陈代谢

呼吸 & 免疫学

疫苗 & 免疫疗法

神经科学

Alexion 罕见的疾病s

Scientific capabilities

Our unique scientific capabilities enable us to deliver what we believe to be one of the most productive pipelines in the industry.

We have built and invested in cutting-edge technologies to enable us to fast-forward the pace of our science, helping us achieve the next wave of breakthroughs and do things that have never been done before.

In our quest to transform disease, we believe it is essential to target novel biology we uncover. We are continuing to design new ways to target the drivers of disease to help us create the next generation of therapeutics.

Data Science and AI have the potential to transform the way we discover and develop new medicines. We hope to be able to increase the probability of success and reduce timelines in our drug discovery and development process by applying advanced AI and machine learning across R&D.